PAUL H. NOTH, M.D., M.S. (in Medicine); HANS H. HECHT, M.D.; FREDERICK F. YONKMAN, M.D., PH.D.
The chemical composition and pharmacologic properties of demerol have been described in a separate communication.1 The present report deals with clinical observations of the actions of this drug. Since 1939 a great number of clinical reports on demerol (variously called Dolantin, Dolantol, Alba, D-140, S-140) have appeared in the South American and European literature including observations on more than 2,000 cases. Only a few clinical studies, however, have been published in this country,2, 3, 4, 5, 6, 7 including a series of papers by Himmelsbach and Andrews on tolerance and addiction liabilities in former morphine addicts.8, 9, 10 We have
NOTH PH, HECHT HH, YONKMAN FF. DEMEROL: A NEW SYNTHETIC ANALGETIC, SPASMOLYTIC, AND SEDATIVE AGENT. II. CLINICAL OBSERVATIONS1. Ann Intern Med. ;21:17–34. doi: 10.7326/0003-4819-21-1-17
Download citation file:
Published: Ann Intern Med. 1944;21(1):17-34.
Hospital Medicine, Infectious Disease, Pneumonia, Pulmonary/Critical Care.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use